Zusammenfassung
Unter den Präkanzerosen der Haut wurden eine Reihe verschiedener Erscheinungsbilder herausgestellt, die z.T. nach ihrer Ätiologie und z.T. aufgrund ihrer klinischen Morphe unterschieden werden. Nicht alle der im folgenden aufgeführten Entitäten lassen sich eindeutig voneinander abgrenzen; so kann beispielsweise eine bowenoide aktinische Kera tase.vom M. Bowen weder klinisch noch histologisch eindeutig differenziert werden. Die häufigsten Entitäten, die hier in Frage kommen, sind in der Tabelle 37.1 aufgeführt
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Amon RB, Goodkin PE (1976) Topical 5-fluorouracil and the basal cell nevus syndrome. N Engl J Med 295: 677–678
Bennett RG (1987) Mohs’ surgery. New concepts and applications. Dermatol Clin 5: 409–428
Boneschi V, Brambilla L, Chiappino G et al. (1991) Intralesional alpha 2a recombinant interferon for basal cell carcinoma. In J Dermatol 30: 220–224
Brooks NA (1984) Curettage and shave excision. A tissue saving technic for primary cutaneous carcinoma worthy of inclusion in graduate training programs. J Am Acad Dermatol 10: 279
Buechner St (1991) Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. J Am Acad Dermatol 24: 731–734
Buschmann W, Haigis W (1991) Technik and Ergebnisse der Stickstoff-Kryotherapie von Lidbasaliomen. Klin Monatsbl Augenheilkd 198: 55–58
Caccialanza M, Piccinno R, Beretta MV, Sopelana N (1993) Radiotherapy of Bowen’s disease. Skin Cancer 8: 115–118
Chahbazian CM, Brown GS (1980) Radiation therapy for carcinoma of the skin of the face and neck. Special considerations. J Am Med Assoc 244: 1135–1137
Cornell RC, Greenway HT, Tucker SB et al. (1990) Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 23: 694–700
Cristofolini M, Zumiani G, Scappini P et al. (1984) Aromatic retinoid in the chemoprevention of the progression of nevoid basal-cell carcinoma syndrome. J Dermatol Surg Oncol 10: 778–781
Drake LA, Ceilley RI, Cornelison RL et al. (1992) Guidelines of care for basal cell carcinoma. J Am Acad Dermatol 26: 117–120
Dubin N, Kopf AW (1983) Multivariate risk score for recurrent cutaneous basal cell carcinomas. Arch Dermatol 119: 373–377
Epstein E (1985) Fluorouracil paste treatment of the basal cell carcinoma. Arch Dermatol 121: 207–213
Greenberg ER, Baron JA, Stukel TA et al. (1990) A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med 323: 789–795
Greenway HT, Cornell RC, Tanner DJ et al. (1986) Treatment of basal cell carcinoma with intralesional interferon. J Am Acad Dermatol 15: 437–443
Grob JJ, Collet AM, Munoz MH, Bonerandi JJ (1988) Treatment of large basal-cell carcinomas with intralesional interferon-alpha-2a (letter). Lancet 1: 878–879
Guthrie TH, McElveen U, Porubsky ES, Harmon JD (1985) Cisplatin and doxorubicin: An effective chemotherapy combination in the treatment of advanced basal cell and squamous cell carcinoma of the skin. Cancer 55: 1629–1632
Hauben DJ, Zirkin H, Mahler D, Sachs M et al. (1982) The biologic behavior of basal cell carcinoma: Analysis of recurrence in excised basal cell carcinoma II. Plast Reconstr Surg 69: 110–116
Hodak E, Ginzburg A, David M et al. (1987) Etretinate treatment of the nevoid basal cell carcinoma syndrome. Therapeutic and chemopreventative effect. Int J Dermatol 26: 606–609
Hughes BR, Marks R, Pearse AD, Gaskell SA (1988) Clinical response and tissue effects of etretinate treatment of patients with solar keratoses and basal cell carcinoma. J Am Acad Dermatol 18: 522–529
Johnson TM, Tromovitch TA, Swanson NA (1991) Combined curettage and excision: a treatment method for primary basal cell carcinoma. J Am Acad Dermatol 24: 613–617
Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with exogenous photoporphyrin. J Photobiol 6: 134–138
Khandekar JD (1990) Complete response of metastatic basal cell carcinoma to cisplatin chemotherapy: a report on two patients (letter). Arch Dermatol 126: 1660
Kligman LH, Akin FJ, Kligman AM (1980) Sunscreens prevent ultraviolet photocarcinogenesis. J Am Acad Dermatol 3: 30–35
Kowalzick L, Rogozinski T, Schober C et al. (1994) Treatment of basal cell carcinoma with intralesional recombinant interferon beta: a dose-finding study. Eur J Dermatol 4: 430–433
Kraemer KH, DiGiovanna JJ, Moshell AN et al. (1988) Prevention of skin cancer in xeroderma pigmento-sum with the use of oral isotretinoin. N Engl J Med 318: 1633–1637
Kuflik EG (1985) Cryosurgery for carcinoma of the eyelids. A 12-year experience. J Dermatol Surg Oncol 11: 243–246
Lang PG Jr, Maize JC (1991) Basal Cell Carcinoma. In: Friedman RJ, Rigel DS, Kopf AW et al. (eds) Cancer of the skin. Saunders, Philadelphia, pp 35–73
Lo JS, Snow SN, Reizner GT et al. (1991) Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol 24: 715–719
McDaniel WE (1983) Therapy for basal cell epitheliomas by curettage only. Further study. Arch Dermatol 119: 901–903
McLaughan JS, Gay JT, Hicks W et al. (1989) Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. Arch Surg 124: 211–216
McLean DI, Haynes HA, McCarthy PL, Baden HP (1978) Cryotherapy of basal cell carcinoma by a simple method of standardized freeze-thaw cycles. J Dermatol Surg Oncol 4: 175–177
Peck GL (1987) Long-term retinoid therapy is needed for maintenance of cancer chemopreventive effect. Dermatologica 175: 138–144
Peck GL, DiGiovanna JJ, Sarnoff DS et al. (1988) Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol 19: 176–185
Riefkohl R, Pollack S, Georgiade GS (1985) A rationale for the treatment of difficult basal cell and squamous cell carcinoma of the skin. Ann Plast Surg 15: 99–104
Robinson JK (1987) Use of a combination of chemotherapy and radiation therapy in the management of advanced basal cell carcinoma of the head and neck. J Am Acad Dermatol 17: 770–774
Robinson JK (1987) What are adequate treatment and following care for nonmelanoma cutaneous cancer? Arch Dermatol 123: 331–333
Roenigk RK, Ratz JL, Bailin PL, Wheeland RG (1986) Trends in the presentation and treatment of basal cell carcinomas. J Dermatol Surg Oncol 12: 860–865
Sacchini V, Lovo GF, Avioli N et al. (1984) Carbon dioxide laser in scalp tumor surgery. Laser Surg Med 4: 261–269
Sachini V, Melloni E, Marchesini R et al. (1987) Preliminary clinical studies with PDT by topical TPPS in neoplastic skin lesions. Lasers Surg Med 7: 6–11
Spiller WF, Spiller RF (1984) Treatment of basal cell epithelioma by curettage and electrodesiccation. J Am Acad Dermatol 11: 808–814
Suhge d’Aubermont PC, Bennett RG (1984) Failure of curettage and electrodesiccation for removal of basal cell carcinoma. Arch Dermatol 120: 1456–1460
Tsuji T, Otake N, Nishimura M (1993) Cryosurgery and topical fluorouracil: A treatment method for wide spread basal cell epithelioma in basal cell nevus syndrome. J Dermatol 20: 507–513
Wickramasinghe L, Hindson TC, Wacks M (1989) Treatment of neoplastic skin lesions with intralesional interferon. J Am Acad Dermatol 20: 70–74
Wolf P, Rieger E, Kerl H (1993) Topical photodynamic therapy with endogenous prophyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 28: 17–21
Zacarian SA (1985) Complications, indications, and contraindications in cryosurgery. In: Zacarian SA (ed) Cryosurgery for skin cancer and cutaneous disorders. Mosby, St Louis, p 283
Cassisi NJ (1989) Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 16: 25–36
Clark JR, Dreyfuss AI (1991) The role of cisplatin in treatment regimens for squamous cell carcinoma of the head and neck. Semin Oncol 18 [Suppl 3]: 34–48
Cognetti F, Pinnaro P, Ruggeri EM et al. (1989) Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer. J Clin Oncol 7: 829–837
Dreyfuss AI, Clark JR, Wright JE et al. (1990) Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med. 112: 167–172
Chahbazian CM, Brown GS (1980) Radiation therapy for carcinoma of the skin of the face and neck. Special considerations. J Am Med Assoc 244: 1135–1137
Gollnick H, Orfanos CE (1991) Theoretical aspects of the use of retinoids as anticancer agents. In: Marks R (ed) Retinoids in cutaneous malignancy. Blackwell, Oxford, pp 41–65
Greenberg ER, Baron JA, Stukel TA et al. (1990) A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med 323: 789–795
Guthrie TH Jr, McElveen LJ, Porubsky ES et al. (1985) Cisplatin and doxorubicin. An effective chemotherapy in the treatment of advanced basal cell and squamous carcinoma of skin. Cancer 55: 629–632
Guthrie TH Jr, Porubsky RS, Luxenberg MN (1990) Cisplatin-based chemotherapy of advanced basal and squamous cell carcinomas of the skin: Results in 28 patients including 13 patients receiving multimodality therapy. J Clin Oncol 8: 342–346
Harrison LB, Pfister DG, Fass DE et al. (1991) Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol biol Phys 21: 703–708
Hong WK, Lippmann SM, Itri LM et al. (1990) Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 323: 795–801
Jacobs JR, Pajak TF, al-Sarraf M et al. (1989) Chemotherapy following surgery for head and neck cancer. A Radiation Therapy Oncology Group Study. Am J Clin Oncol 12: 185–189
Khafif RA, Gelbfish GA, Tepper P, Attie JN (1991) Elective radical neck dissection in epidermoid cancer of the head and neck. A retrospective analysis of 853 cases of mouth, pharynx and larynx cancer. Cancer 67: 67–71
Khansur T, Kennedy A (1991) Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin. Cancer 67: 2020–2032
Kuflik EG, Gage AA (1991) The five-year cure rate achieved by cryosurgery for skin cancer.J Am Acad Dermatol 24: 1002–1004
Lippman SM, Meyskens FL Jr (1987) Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med 107: 499–502
Lippman SM, Parkinson DR, Itri LM et al. (1992) 13cis-Retinoic acid and interferon a-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84: 235–241
Miller RA, Spittle MF (1982) Electron beam therapy for difficult cutaneous basal and squamous cell carcinomas. Br J Dermatol 106: 429–436
Mohs FE (1978) Chemosurgery: Microscopically controlled surgery for skin cancer. Thomas, Springfield/ IL
Müller KP, Zouboulis CC, Garbe C (1990) Antionkogramm-orientierte Polychemotherapie bei metastasierendem Plattenepithelkarzinom der Haut: eindrucksvolle partielle Remission. Hautarzt 41: 566–568
Paccagnella A, Pappagallo GL, Segati R et al. (1990) Response and toxicity of cisplatin and 120-h 5-fluorouracil infusion in pretreated and untreated patients with advanced epidermoid cancer of the head and neck. Am J Clin Oncol 13: 194–198
Sadek H, Azli N, Wendling JL et al. (1990) Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorourazil and bleomycin. Cancer 66: 1692–1696
Schweitzer VG (1990) Photodynamic therapy for treatment of head and neck cancer. Otolaryngol Head Neck Surg 102: 225–232
Vokes EE, Mick R, Lester EP et al. (1991) Cisplatin and fluorouracil chemotherapy does not yield longterm benefit in locally advanced head and neck cancer: results from a single institution. J Clin Oncol 9: 1376–1384
Wells G, Koh WJ, Pelton J et al. (1989) Fast neutron teletherapy in advanced epidermoid head and neck cancer. Am J Clin Oncol 12: 295–400
Balducci L, Athar M, Smith GF et al. (1988) Metastatic extramammary Paget’s disease: dramatic response to combined modality treatment. J Surg Oncol 38: 38–44
Balducci L, Crawford ED, Smith GF et al. (1988) Extramammary Paget’s disease: an annotated review. Cancer Invest 6: 293–303
Brierley JD, Stockdale AD (1991) Radiotherapy: an effective treatment for extramammary Paget’s disease. Clin Oncol R Coll Radiol 3: 3–5
Chanda JJ (1985) Extramammary Paget’s disease: Prognosis and relationship to internal malignancy. J Am Acad Dermatol 13: 1009–1014
Coldiron BM, Goldsmith BA, Robinson JK (1991) Surgical treatment of extramammary Paget’s disease. A report of six cases and a reexamination of Mohs micrographic surgery compared with conventional surgical excision. Cancer 67: 933–938
Degefu S, O’Quinn AG, Dhurandhar HN (1986) Paget’s disease of the vulva and urogenital malignancies: A case report and review of the literature. Gynecol Oncol 25: 347–354
Eliezri YD, Silvers DN, Horan DB (1987) Role of preoperative topical 5-fluorouracil in preparation for Mohs micrographic surgery of extramammary Paget’s disease. J Am Acad Dermatol 17: 497–505
Jones RE, Austin C, Ackerman AB (1979) Extramammary Paget’s disease. A critical reexamination. Am J D ermatop athol 1: 101–132
Lupton GP, Graham JH (1991) Mammary and extra-mammary Paget’s disease. In: Friedman RJ, Rigel DS, Kopf AW et al. (eds) Cancer of the skin. Saunders, Philadelphia, pp 219–236
Mohs FE, Blanchard L (1979) Microscopically controlled surgery for extramammary Paget’s disease. Arch Dermatol 115: 706–708
Wada H, Urabe H (1984) Surgical treatment of genital Paget’s disease in men. Ann Plast Surg 13: 199–204
Wagner RF, Cottel WI (1988) Treatment of extensive extramammary Paget disease of male genitalia with Mohs micrographic surgery. Urology 31: 415–418
Yokoyama Y, Mabuchi M, Kawabata I et al. (1990) Metastatic vulvar Paget’s disease responding to combination chemotherapy: case report. Jpn J Clin Oncol 20: 426–460
Andrew JE, Silvers DN, Lattes R (1991) Merkel cell carcinoma. In: Friedman RJ, Rigel DS, Kopf AW et al. (eds) Cancer of the skin. Saunders, Philadelphia, pp 288–295
Ashby MA, Jones DH, Tasker AD et al. (1989) Primary cutaneous neuroendocrine (Merkel cell or trabecular carcinoma) tumour of the skin: a radioresponsive tumour. Clin Radiol 40: 85–87
Azagury M, Chevalier B, Atlan D et al. (1993) VP-16, cisplatin, doxorubicin and bleomycin in metastatic Merkel cell carcinoma. Am J Clin Oncol 16: 102–104
Bacchiocchi M, Brusco JE, Brusco HA (1993) Carcinoma de células de Merkel. Revision. Arch Argent Dermatol XLIII, 285–308
Brierley JD, Stockdale AD, Rostom AY (1991) Merkel cell (trabecular) carcinoma of skin treated by radiotherapy. Clin Oncol R Coll Radiol 3: 117–118
Davis MP, Miller EM, Rau RC et al. (1990) The use of VP16 and cisplatin in the treatment of Merkel cell carcinoma. J Dermatol Surg Oncol 16: 276–278
Duncan WCh, Tschen JA (1993) Spontaneous regression of Merkel cell (neuroendocrine) carcinoma of the skin. J Am Acad Dermatol 29: 653–654
Fenig E, Lurie H, Sulkes A (1993) The use of cyclophosphamide, methotrexate and 5-fluorouracil in the treatment of Merkel cell carcinoma. Am J Clin Oncol 16: 54–57
Ferran F, Innocenzi D (1993) Primary Merkel cell tumor: a clinical analysis of eight cases. Int J Dermatol 32: 345–349
Feun LG, Savaraj N, Legha SS et al. (1988) Chemotherapy for metastatic Merkel cell carcinoma. Review of the M.D. Anderson Hopital’s experience. Cancer 62: 683–685
Hanke WC, Conner AC, Temofeew RK, Lingeman RE (1989) Merkel cell carcinoma. Arch Dermatol 125: 1096–1100
Hasle H (1991) Merkel cell carcinoma: the role of primary treatment with radiotherapy. Clin Oncol R Coll Radiol 3: 114–116
Hitchcock CL, Bland KI, Laney RG et al. (1988) Neuroendocrine (Merkel cell) carcinoma of the skin; its natural history, diagnosis and treatment Ann Surg 207: 201–207
Ito Y, Kawamura K, Miura T et al. (1989) Merkel cell carcinoma. A successful treatment with tumor necrosis factor. Arch Dermatol 125: 1093–1095
Kayashima K, Ono T, Johno M et al. (1991) Spontaneous regression in Merkel cell (neuroendocrine) carcinoma of the skin. Arch Dermatol 127: 550–553
Knox SJ, Kapp DS (1988) Hyperthermia and radiation therapy in the treatment of recurrent Merkel cell tumors. Cancer 62: 1479–1486
Mercer D, Brander P, Liddell K (1990) Merkel cell carcinoma: the clinical course. Ann Plast Surg 25: 136–141
Mills CH, Anstey AV, Williams N, Holt PJA (1994) Primary neuroendocrine carcinoma of the skin ( PNCS); report of a case and reviews of current concepts. Eur J Dermatol 4: 456–458
Morrison WH, Peters LJ, Silva EG et al. (1990) The essential role of radiation therapy in securing locore-gional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 19: 583–591
Raaf JH, Urmacher C, Knapper WK et al. (1986) Trabecular (Merkel cell) carcinoma of the skin. Treatment of primary, recurrent and metastatic disease. Cancer 57: 178–182
Redmond J III, Perry J, Sowray P et al. (1991) Chemotherapy of disseminated Merkel-cell carcinoma. Am J Clin Oncol 14: 305–307
Ronan SG, Green AD, Shilkaitis A (1993) Merkel cell carcinoma: In vitro and in vivo characteristics of a new cell line. J Am Acad Dermatol 25: 715–722
Sharma D, Flora G, Grunberg SM (1991) Chemotherapy of metastatic Merkel cell carcinoma: case report and review of the literature. Am J Clin Oncol 14: 166–169
Shaw JH, Rumball E (1991) Merkel cell tumour: clini- cal behaviour and treatment. Br J Surg 78: 138–142
Sibley RK, Dehner LP, Rosai J (1985) Primary neuro-endocrine (Merkel cell?) carcinoma of the skin. I. A clinicopathological and ultrastructural study of 43 cases. Am J Surg Pathol 9: 95–100
Hashimoto K (1991) Adnexal carcinoma of the skin. In: Friedman RJ, Riegel DS, Kopf AW et al. (eds) Cancer of the skin. Saunders, Philadelphia, pp 209–218
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Orfanos, C.E., Garbe, C. (1995). Epitheliale Präkanzerosen und Karzinome der Haut. In: Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97602-5_37
Download citation
DOI: https://doi.org/10.1007/978-3-642-97602-5_37
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97603-2
Online ISBN: 978-3-642-97602-5
eBook Packages: Springer Book Archive